💊
Cinryze
C1 inhibitor (human)
Hereditäre Angioödeme
✅ Autorisiert
✅
Keine aktiven Warnungen
Dieses Arzneimittel unterliegt derzeit keinen Lieferengpässen, Sicherheitshinweisen oder Rückrufen.
Wofür es verwendet wird
Treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults, adolescents and children (6 years old and above) with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.
⚠️ Patientensicherheit
No
📚 Vergangene Warnungen (2)
Offizielle EMA-Seite
https://www.ema.europa.eu/en/medicines/human/EPAR/cinryze